We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Kura Oncology
KURA
$841M
| $536K | ﹤0.01% |
43,840
| – | – |
|
1252
Woodside Energy
WDS
$42.6B
| $530K | ﹤0.01% |
23,633
-506
| -2% | -$12.2K |
|
1253
AMC Global Media
AMCX
$501M
| $527K | ﹤0.01% |
30,000
+10,000
| +50% | +$187K |
|
1254
Webster Financial
WBS
$12.6B
| $521K | ﹤0.01% |
13,205
+160
| +1% | +$7.68K |
|
1255
Bentley Systems
BSY
$11B
| $516K | ﹤0.01% |
12,000
+107
| +0.9% | +$4.25K |
|
|
CCRN
1256
DELISTED
Cross Country Healthcare
CCRN
| $516K | ﹤0.01% |
23,100
+14,800
| +178% | +$388K |
|
1257
DNOW Inc
DNOW
$2.63B
| $515K | ﹤0.01% |
46,200
+11,000
| +31% | +$138K |
|
1258
HEICO Corp
HEI
$51.4B
| $513K | ﹤0.01% |
3,000
+96
| +3% | +$16.2K |
|
1259
Diodes
DIOD
$4.06B
| $510K | ﹤0.01% |
5,500
| – | – |
|
|
BCYC
1260
Bicycle Therapeutics
BCYC
$275M
| $502K | ﹤0.01% |
23,586
| – | – |
|
1261
Gibraltar Industries
ROCK
$1.43B
| $501K | ﹤0.01% |
10,328
-31,206
| -75% | -$1.6M |
|
1262
Aura Biosciences
AURA
$740M
| $501K | ﹤0.01% |
53,956
| – | – |
|
1263
Helmerich & Payne
HP
$3.45B
| $501K | ﹤0.01% |
14,000
+3,100
| +28% | +$134K |
|
1264
Banner Corp
BANR
$2.44B
| $500K | ﹤0.01% |
9,200
| – | – |
|
1265
Designer Brands
DBI
$336M
| $497K | ﹤0.01% |
56,900
+33,100
| +139% | +$318K |
|
1266
Virtus Investment Partners
VRTS
$1.11B
| $495K | ﹤0.01% |
+2,600
| New | +$526K |
|
1267
Genesco
GCO
$439M
| $479K | ﹤0.01% |
13,000
+3,300
| +34% | +$145K |
|
1268
Maximus
MMS
$3.33B
| $472K | ﹤0.01% |
6,000
-4,500
| -43% | -$347K |
|
1269
Franklin Electric
FELE
$4.86B
| $471K | ﹤0.01% |
5,000
+400
| +9% | +$36.1K |
|
1270
MakeMyTrip
MMYT
$5.95B
| $470K | ﹤0.01% |
19,219
| – | – |
|
1271
Kimbell Royalty Partners
KRP
$1.44B
| $467K | ﹤0.01% |
30,640
| – | – |
|
|
SWTX
1272
DELISTED
SpringWorks Therapeutics
SWTX
| $466K | ﹤0.01% |
18,116
+2,500
| +16% | +$73.1K |
|
1273
Immunovant
IMVT
$8.08B
| $464K | ﹤0.01% |
29,900
+11,100
| +59% | +$193K |
|
1274
Dutch Bros
BROS
$8.8B
| $458K | ﹤0.01% |
14,488
| – | – |
|
1275
Healthcare Realty
HR
$7.02B
| $456K | ﹤0.01% |
23,600
-100
| -0.4% | -$2.02K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.